Ergebnisse einschränken

In Vitro Effects of DuP 753, a Nonpeptide Angiotensin II Receptor Antagonist, on Human Platelets and Rat Vascular Smooth Muscle Cells

Burnier, Michel ; Centeno, Gabriel ; Grouzmann, Eric ; Walker, Philippe ; Waeber, Bernard ; Brunner, Hans R.

In: American Journal of Hypertension, 1991, vol. 4, no. 5_Pt_1, p. 438-443

A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes

Barbey, Frédéric ; Bonny, Olivier ; Rothuizen, Laura ; Gomez, Fulgencio ; Burnier, Michel

In: Nephrology Dialysis Transplantation, 2003, vol. 18, no. 10, p. 2193-2196

Renal perfusion evaluation with contrast-enhanced ultrasonography

Schneider, Antoine G. ; Hofmann, Lucie ; Wuerzner, Grégoire ; Glatz, Nicolas ; Maillard, Marc ; Meuwly, Jean-Yves ; Eggimann, Philippe ; Burnier, Michel ; Vogt, Bruno

In: Nephrology Dialysis Transplantation, 2012, vol. 27, no. 2, p. 674-681

P-621: Metabolic determinants of proximal sodium reabsorption in healthy women

Zanchi, Anne ; Bochud, Murielle ; Decosterd, Dumeng ; Maillard, Marc ; Burnier, Michel

In: American Journal of Hypertension, 2003, vol. 16, no. S1, p. 263A-263A

Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension

Guessous, Idris ; Dobrinas, Maria ; Kutalik, Zoltán ; Pruijm, Menno ; Ehret, Georg ; Maillard, Marc ; Bergmann, Sven ; Beckmann, Jacques S. ; Cusi, Daniele ; Rizzi, Federica ; Cappuccio, Franco ; Cornuz, Jacques ; Paccaud, Fred ; Mooser, Vincent ; Gaspoz, Jean-Michel ; Waeber, Gérard ; Burnier, Michel ; Vollenweider, Peter ; Eap, Chin B. ; Bochud, Murielle

In: Human Molecular Genetics, 2012, vol. 21, no. 14, p. 3283-3292

O-28: Molecular basis for the insurmountable AT-1 receptor antagonism of telmisartan

Maillard, Marc P. ; Centeno, Catherine ; Wienen, Wolfgang ; Brunner, Hans R. ; Burnier, Michel

In: American Journal of Hypertension, 2001, vol. 14, no. S1, p. 12A-13A

Incidence, complications and risk factors for severe falls in patients on maintenance haemodialysis

Rossier, Alain ; Pruijm, Menno ; Hannane, Dores ; Burnier, Michel ; Teta, Daniel

In: Nephrology Dialysis Transplantation, 2012, vol. 27, no. 1, p. 352-357

P-537: Pioglitazone blunts the blood pressure response to angiotensin II in insulin-resistant zucker rats

Zanchi, Anne ; Perregaux, Christine ; Maillard, Marc ; Nussberger, Juerg ; Brunner, Hans R. ; Burnier, Michel

In: American Journal of Hypertension, 2003, vol. 16, no. S1, p. 232A-232A

Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain

Aubert, Gregory ; Burnier, Michel ; Dulloo, Abdul G. ; Perregaux, Christine ; Mazzolai, Lucia ; Pralong, François ; Zanchi, Anne

In: Metabolism - Clinical and Experimental, 2010, vol. 59, no. 1, p. 25-32

Telmisartan is an angiotensin II receptor blocker with peroxisome proliferator–activated receptor–γ agonistic properties. Telmisartan prevents weight gain and decreases food intake in models of obesity and in glitazone-treated rodents. This study further investigates the influence of telmisartan and pioglitazone and their association on weight gain and body composition by examining...

Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties

Zanchi, Anne ; Dulloo, Abdul G. ; Perregaux, Christine ; Montani, Jean-Pierre ; Burnier, Michel

In: American Journal of Physiology - Endocrinology and Metabolism, 2007, vol. 293, p. E91-E95

Glitazones are peroxisome proliferator-activated receptor (PPAR)-Γ agonists with powerful insulin-sensitizing properties. They promote the development of metabolically active adipocytes that can lead to a substantial gain in fat mass. Telmisartan is an ANG II type 1 receptor antagonist with partial PPAR-Γ agonistic properties. Recently, telmisartan has been reported to prevent weight gain and...